ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Livostin Augentropfen, Augentropfensuspension - 4 ml
50496023 JNTL Consumer Health II (Switzerland) GmbH
Livostin Augentropfen, Augentropfensuspension28.02.1992
  28.02.1992
Levocabastine (S01GX02)27.11.2006
WHO-DDD 
11.06.20.4 ml
11.06.20. 
D  
Yes 
IPCI
7.22No
    
10 %13.35
  
7680504960234Synthetika
1439904 
Composition
levocabastinum 0.5 mg ut levocabastini hydrochloridum, propylenglycolum, dinatrii phosphas et natrii dihydrogenophosphas monohydricus corresp. phosphas 9.5 mg, benzalkonii chloridum 0.15 mg, hypromellosum, polysorbatum 80, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Augentropfensuspension 
  
 
Active AgentDose
Levocabastine0.5 mg/ml
BAG: Active AgentDose
Levocabastine0.5 mg
 
Inactive agentsDose
Benzalkonium Chloride0.15 mg/ml
Dinatrii Edetas 
Disodium Phosphate 
Hypromellosum 
Sodium Dihydrogenophosphate Monohydrate 
Polysorbatum 80 
Propylenglycol 
 
Source
Data was imported : 04.05.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home